Which has the lower trailing P/E, DMAA or VABK?

VABK has the lower trailing P/E: DMAA trades at 55.48 and VABK at 10.56. P/E is one valuation measure and does not by itself establish which business is cheaper.

Does DMAA or VABK pay a bigger dividend?

VABK pays a dividend (3.01% yield), while DMAA has no payments in the available dividend history.

Is DMAA or VABK more profitable?

VABK runs the higher net margin — DMAA at 0.00% versus VABK at 28.18%.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) vs Virginia National Bankshares Corporation (VABK)

A side-by-side comparison of Drugs Made In America Acquisition Corp. Ordinary Shares and Virginia National Bankshares Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares

$264M

$10.89Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT

VABK

Virginia National Bankshares Corporation

$261M

$48.15Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — DMAA vs VABK

growth of $100 · dividends reinvested · last 2y

DMAA +9.3% (+4.6%/yr)VABK +41.0% (+18.7%/yr)VABK compounded faster over this window

DMAA VABK

DMAA vs VABK: by the numbers

•DMAA is the larger company ($264M vs $261M market cap).
•VABK trades at the lower trailing earnings multiple (10.56 vs 55.48 P/E), one valuation lens rather than an overall verdict.
•VABK is profitable (28.18% net margin) while DMAA runs a net loss (0.00%).
•VABK pays a dividend (3.01% yield), while DMAA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DMAA	VABK
P/E ratio	55.48	10.56
PEG ratio	N/A	2.80
P/S ratio	N/A	2.97
P/B ratio	1.92	1.34

Profitability

Metric	DMAA	VABK
Gross margin	0.00%	N/A
Operating margin	0.00%	35.31%
Net margin	0.00%	28.18%
ROE	4.42%	12.74%
ROIC	-1.82%	N/A

Virginia National Bankshares Corporation: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.

Dividends

Metric	DMAA	VABK
Dividend yield	N/A	3.01%
Payout ratio	N/A	31.58%

Growth (annualized)

Metric	DMAA	VABK
Revenue CAGR (5Y)	N/A	15.77%
EPS CAGR (5Y)	N/A	3.89%
Total return CAGR (5Y)	N/A	10.05%

Frequently asked

Which has the lower trailing P/E, DMAA or VABK?: VABK has the lower trailing P/E: DMAA trades at 55.48 and VABK at 10.56. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does DMAA or VABK pay a bigger dividend?: VABK pays a dividend (3.01% yield), while DMAA has no payments in the available dividend history.
Is DMAA or VABK more profitable?: VABK runs the higher net margin — DMAA at 0.00% versus VABK at 28.18%.

Go deeper

Full DMAA analysis Full VABK analysis Interactive comparison tool

Dig into the metrics

Drugs Made In America Acquisition Corp. Ordinary Shares P/E ratio Virginia National Bankshares P/E ratio Virginia National Bankshares dividend yield Drugs Made In America Acquisition Corp. Ordinary Shares ROE Virginia National Bankshares ROE Drugs Made In America Acquisition Corp. Ordinary Shares operating margin Virginia National Bankshares operating margin Drugs Made In America Acquisition Corp. Ordinary Shares revenue growth Virginia National Bankshares revenue growth Drugs Made In America Acquisition Corp. Ordinary Shares free cash flow

Drugs Made In America Acquisition Corp. Ordinary Shares & Virginia National Bankshares appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest Operating Margin Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.